Distinct predictive factors influence on achievement of early molecular response by frontline imatinib in chronic phase chronic myeloid leukemia.
Leuk Res
; 39(4): 411-8, 2015 Apr.
Article
in En
| MEDLINE
| ID: mdl-25680524
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperazines
/
Pyrimidines
/
Benzamides
/
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Biomarkers, Tumor
/
Antineoplastic Agents
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Leuk Res
Year:
2015
Document type:
Article